2020 annual financial data
Foghorn Therapeutics 2020 Operating cash flow
Direct answer
Operating cash flow was -31,286,000 USD.
Operating income was -68,531,000 USD and net income was -68,800,000 USD.
Operating cash flow was -31,286,000 USD.
Get free Foghorn Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 430,000 USD
- Operating income
- -68,531,000 USD
- Net income
- -68,800,000 USD
- Operating cash flow
- -31,286,000 USD